Portage Biotech Inc.
Climate Impact & Sustainability Data (2018)
Reporting Period: 2018
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Delay in manufacturing lead drug candidate IMM60 due to quality failures in the manufacturing process (iOx Therapeutics).
Mitigation Strategies
- iOx is planning to initiate multiple human clinical studies in 2019. iOx will use proceeds from additional funding to facilitate preparing regulatory submissions for two first in human studies in 2019.